Shahlaa Zuhair Abdul-Majeed

Shahlaa Zuhair Abdul-Majeed

Auto-generated profile, based on publicly available information

Shahlaa Zuhair Abdul-Majeed

Pharmaceutical Chemistry Department, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
Verified
Journal Article
Open access
PDF file
SYShuhad Yaseen
Shuhad Yaseen
SAShahlaa Zuhair Abdul-Majeed
Shahlaa Zuhair Abdul-Majeed
SHSarah Ashour Hamood
Sarah Ashour Hamood
Background: Alzheimer disease (AD) is the most common type of dementia, which is still a problem that everyone must deal with. In a continuous effort to find effective treatments, the new candidates for AD therapy have the capacity to scavenge excessive levels of free radicals and inhibit acetylcholinesterase (AChE). Objectives: This study focuses on synthesizing and biologically evaluating novel hybrid compounds (1-3) as acetylcholine esterase inhibitors. Methods: The benzimidazole has been added and then coupled with coumaric acid, cinnamic acid, and lipoic acid as conjugates, which are expected to have dual action as acetylcholinesterase inhibitors and antioxidants. The synthesis of benzimidazole derivatives (1-3) was accomplished and then characterized using 1H-NMR and elemental analysis. Additionally, their characteristics were assessed in vitro against the AChE enzyme. Results: The new compounds produced a potent inhibitory activity that may serve as a lead molecule for the synthesis of novel anti-AD molecules. Compound-1 has an inhibition percentage that is close to that of the authorized medication galantamine (95.386%), whereas compound-3 has the lowest inhibition percentage (88.647%). Conclusions: A very good yield was achieved during the synthesis of the benzimidazole derivatives (1-3) from the starting material. They can serve as potential candidates for acetylcholine esterase inhibitors.

21 October 2022 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Closed access
SAShahlaa Zuhair Abdul-Majeed
Shahlaa Zuhair Abdul-Majeed
SHSarah Ashour Hamood
Sarah Ashour Hamood
ADAshour H. Dawood
Ashour H. Dawood

23 July 2026 in Journal of Emergency Medicine, Trauma and Acute Care
Verified
Journal Article
Open access
SAShahlaa Zuhair Abdul-Majeed
Shahlaa Zuhair Abdul-Majeed
JAJumana Suhban Sulaiman Almallah
Jumana Suhban Sulaiman Almallah
SYShuhad Yaseen
Shuhad Yaseen
Background: Vitamin D and omega-3 (ω-3) have garnered significant attention in the scientific community due to their ability to exert various non-classical activities on the body, and multifaceted roles in maintaining overall health. Hence, a good understanding of the potential effect of vitamin D and ω-3 in developing and progressing type-1 diabetes mellitus (T1DM) can assist in controlling clinical advancement of the disease. Aims: The current study aimed to experimentally induce T1DM to investigate the role of vitamin D, omega-3, and their combination on the activity of lipid profile, liver enzymes, and antioxidant markers. Materials and methods: A total of 75 young male mice were divided equally into five groups. Initially, T1DM was induced in PC, EG1, EG2, and EG3 by a single high dose of streptozotocin. Mice were treated daily with vitamin D (EG1), ω-3 (EG2), and a combination of both (EG3). After 12 weeks, mice were euthanized and blood was collected to be tested using quantitative specific ELISA kits for the measurement of different blood biomarkers. Results: In comparison to the values of PC, administration of vitamin D for mice of EG1 and ω-3 for mice of EG2 significantly lowered the levels of blood glucose, total cholesterol, LDL, triglyceride, ALT, AST, and MDA, as well as increasing the concentrations of HDL, catalase, GPX, and SOD. The highest ameliorative effect was shown in mice of EG3 that were administered a combination of vitamin D and ω-3. Conclusion: This study may represent the first study in Iraq that investigates the effect of vitamin D and ω-3 on the health status of T1DM in mice. However, the translation of these findings into clinical practice remains a challenge, underscoring the need for continued investigation to fully understand the multifaceted impact of vitamin D on human health.